A Study of rhBMP-2/CPM in Closed Fractures of the Humerus

NCT ID: NCT00384852

Last Updated: 2013-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

139 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to assess whether fracture union is accelerated in subjects with humeral fractures (proximal,diaphyseal) treated with conservative therapy (standard of care) and a single dose of rhBMP-2/CPM compared to subjects who receive standard of care alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

1.0 mg/mL rhBMP-2/CPM + SOC

Group Type EXPERIMENTAL

rhBMP-2/CPM

Intervention Type DRUG

B

2.0 mg/mL rhBMP-2/CPM + SOC

Group Type EXPERIMENTAL

rhBMP-2/CPM

Intervention Type DRUG

C

Buffer/CPM + SOC

Group Type ACTIVE_COMPARATOR

rhBMP-2/CPM

Intervention Type DRUG

D

Standard of Care Alone (SOC)

Group Type OTHER

rhBMP-2/CPM

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rhBMP-2/CPM

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Skeletally mature subjects age 18 years or older.
* Subjects with either a closed proximal humeral fracture or a diaphyseal humeral fracture.
* Treatment plan that includes only conservative (nonoperative) therapy within 48 hours following injury.

Exclusion Criteria

* Shoulder dislocation at the time of injury.
* Planned procedure(s) at that would stimulate fracture union at the time of application of the initial immobilization device.
* Fractures located in the distal third of humerus.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Monitor

Role: STUDY_DIRECTOR

Wyeth is now a wholly owned subsidiary of Pfizer

Trial Manager

Role: PRINCIPAL_INVESTIGATOR

For Brazil, [email protected]

Trial Manager

Role: PRINCIPAL_INVESTIGATOR

For Mexico, [email protected]

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Little Rock, Arkansas, United States

Site Status

Aurora, Colorado, United States

Site Status

Denver, Colorado, United States

Site Status

Clearwater, Florida, United States

Site Status

St. Petersburg, Florida, United States

Site Status

Brooklyn, New York, United States

Site Status

Monroe, North Carolina, United States

Site Status

Toledo, Ohio, United States

Site Status

State College, Pennsylvania, United States

Site Status

Herston, Queensland, Australia

Site Status

Adelaide, South Australia, Australia

Site Status

Melbourne, Victoria, Australia

Site Status

São Paulo, São Paulo, Brazil

Site Status

São Paulo, São Paulo, Brazil

Site Status

Vancouver, British Columbia, Canada

Site Status

Ajax, Ontario, Canada

Site Status

Chatham, Ontario, Canada

Site Status

Oshawa, Ontario, Canada

Site Status

Scarborough Village, Ontario, Canada

Site Status

Windsor, Ontario, Canada

Site Status

Montreal, Quebec, Canada

Site Status

Charlottetown, , Canada

Site Status

Oulu, , Finland

Site Status

Turku, , Finland

Site Status

Angers, , France

Site Status

Créteil, , France

Site Status

Berlin, , Germany

Site Status

Münster, , Germany

Site Status

Chihuahua City, Chihuahua, Mexico

Site Status

Guadalajara, Jalisco, Mexico

Site Status

Monterrey, Nuevo León, Mexico

Site Status

D.f., , Mexico

Site Status

Oslo, , Norway

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Bucharest, , Romania

Site Status

Linköping, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Brazil Canada Finland France Germany Mexico Norway Romania Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.

Reference Type DERIVED
PMID: 35727196 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3100N7-212

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non Randomized Humerusshaft Fracture
NCT00205972 COMPLETED PHASE4
Study on Outcomes of Proximal Humerus Fractures
NCT07060664 NOT_YET_RECRUITING NA